Abby Falik, Founder and CEO of 'Global Citizen Year,' discusses the company's mission to make taking a gap year 'aspirational' for all students. Falik adds that the company's goal is to have students develop a new language while getting a new perspective, and showing off what being an American means to other parts of the world. Global Citizen Year offers programs in Ecuador, Senegal, India, and Brazil. Falik adds that the focus of the company is on impact, noting that even though the program is expensive, it is able to choose students, regardless of their financial status, through scholarship programs. The company is a non-profit, and is able to re-invest some tuition costs back into its programs. Falik explains how selective the process is, but that 'Global Citizen Year' does not look at grades or test scores in the way that colleges and universities do. She notes that the program is seeking students that are "persuasive, passionate, and hungry" for a year of impact.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More